
Mechanisms of Disease 2 HC12: How did cancer become the emperor of all maladies?
HC12: How did cancer become the emperor of all maladies?
Overview
Cancer is the emperor of all maladies, the king of all terrors. The attention to and visibility of cancer is growing:
- In Greek and Roman times, cancer was visible but not so prominent
- More and more research of tissues is done
- Around 1900, cancer became a new interest → a public health concern
- The interest in occupational and environmental causes and complexity started growing
Cancer has become a more and more visible disease over the last two centuries. It has developed into the disease of modern times. The disease became a major object of medical, social, economic and political concern.
17th century
In the 17th century, breast cancer was seen as a female disease because only in women it was visible on the outside. Breast amputation was preformed, which had to be done very fast. Of course, men also had breast cancer, but they attributed the signs to something else than a tumor in the body. Breast cancer was connected with lust in sexuality because no breast cancer was found in nuns.
19th century
In the 19th century, a first turning point in cancer history occurred. It was stated that diseases weren’t located throughout the entire body, but could emerge from certain tissues and other parts. There was a localist approach focused on cells, tissues and organs. Doctors opened up a body and found tumors inside. Rudolf Virchow made an important statement: “all cells arise from other cells and malignant cells grow too fast”.
20th century
Early 20th century:
In 1900, the words cancer genetics and oncologist did not exist. Chemotherapy wasn’t present, but a cancer hospital was. Radiation therapy could already be preformed. In 1913, the Netherlands Cancer Institute (NKI) was established.
In the early 20th century, cancer increasingly became a public health problem. This formed a second turning point. It statistically came more to the surface because the life expectancy started to rise. People started thinking more about prevention and control and saw it as “an enemy we have to fight”. Several patterns became visible, such as apprentice chimney sweepers getting scrotal cancer. Between the 1930s and 1960s, surgery underwent huge developments.
Late 20th century:
After World War II, the complexity, risk and genetics of cancer became more and more visible. The erosion of cancer as a social taboo started.
Between the 1960s and 1980s, the relation between environment, behavior and cancer became increasingly visible. This formed a third turning point. For instance, smoking used to be very normal but caused many cases of cancers. Open minded doctors where needed, because the industry would put profit before health. They would create doubt about the relationship between smoking and lung cancer → “more doctors smoke Camels than any other cigarette”. Cancer was described as a single monolithic entity, which isn’t true.
Join with a free account for more service, or become a member for full access to exclusives and extra support of WorldSupporter >>
Mechanisms of Disease 2 2020/2021 UL
- Mechanisms of Disease 2 HC2: Cancer genetics
- Mechanisms of Disease 2 HC3: Cancer biology
- Mechanisms of disease 2 HC4: Cancer etiology
- Mechanisms of disease 2 HC5: Hereditary aspects of cancer
- Mechanisms of Disease 2 HC6: Cancer and genome integrity
- Mechanisms of Disease 2 HC7: Clinical relevance of genetic repair mechanisms
- Mechanisms of Disease 2 HC8: General principles: diagnostic pathology
- Mechanisms of Disease 2 HC9: Nomenclature and grading of cancer
- Mechanisms of Disease 2 HC10: General principles: metastasis
- Mechanisms of Disease 2 HC11: General principles: molecular diagnostics
- Mechanisms of Disease 2 HC12: How did cancer become the emperor of all maladies?
- Mechanisms of Disease 2 HC13: Heterogeneity in cancer
- Mechanisms of Disease 2 HC14: Cancer immunity and immunotherapy
- Mechanisms of Disease 2 HC15: Framework oncology and staging
- Mechanisms of Disease 2 HC16+17: Pharmacology I&II
- Mechanisms of Disease 2 HC18: Biomarkers for early detection of cancer
- Mechanisms of Disease 2 HC19: Surgical oncology
- Mechanisms of Disease 2 HC20: Radiation oncology
- Mechanisms of Disease 2 HC21: Medical oncology
- Mechanisms of Disease 2 HC22: Chemoradiation
- Mechanisms of Disease 2 HC23: Normal hematopoiesis
- Mechanisms of Disease 2 HC24: Diagnostics in hematology
- Mechanisms of Disease 2 HC25: Myeloid malignancies
- Mechanisms of Disease 2 HC26: Malignant lymphomas
- Mechanisms of Disease 2 HC27+28: Allogenic stem cell transplantation and donor lymphocyte infusion I&II
- Mechanisms of Disease 2 HC29: HLA & minor histocompatibility antigens
- Mechanisms of Disease 2 HC30: Changes in patients’ experiences
- Mechanisms of Disease 2 HC31: Targeted therapy and hematological malignancies
- Mechanisms of Disease 2 HC32+33: Primary hemostasis
- Mechanisms of Disease 2 HC34+35: Secondary hemostasis I&II
- Mechanism of Disease 2 HC36: Fibrinolysis and atherothrombosis
- Mechanisms of Disease 2 HC37: Cancer, coagulation and thrombosis
- Mechanisms of Disease 2 HC38: Bleeding disorders
- Mechanisms of Disease 2 HC39: Thrombosis

Contributions: posts
Spotlight: topics
Mechanisms of Disease 2 2020/2021 UL
Deze bundel bevat uitwerkingen van alle hoorcolleges, patientdemonstraties en eventuele (proef)tentamens van het blok Mechanisms of Disease 2 van de studie Geneeskunde aan de universiteit Leiden.
JoHo can really use your help! Check out the various student jobs here that match your studies, improve your competencies, strengthen your CV and contribute to a more tolerant world
Add new contribution